These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 19066923)

  • 1. Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus.
    Tasci Y; Caglar GS; Kayikcioglu F; Cengiz H; Yagci B; Gunes M
    Arch Gynecol Obstet; 2009 Jul; 280(1):39-42. PubMed ID: 19066923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
    Magalhães J; Aldrighi JM; de Lima GR
    Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes.
    Murat Naki M; Tekcan C; Ozcan N; Cebi M
    Fertil Steril; 2010 Jun; 94(1):371-4. PubMed ID: 19896649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
    de Jonge ET; Yigit R; Molenberghs G; Straetmans D; Ombelet W
    Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
    Fong YF; Singh K
    Contraception; 1999 Jul; 60(1):51-3. PubMed ID: 10549453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas.
    Rosa e Silva JC; de Sá Rosa e Silva AC; Cândido dos Reis FJ; Manetta LA; Ferriani RA; Nogueira AA
    J Reprod Med; 2005 Aug; 50(8):613-7. PubMed ID: 16220768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
    Sheng J; Zhang WY; Zhang JP; Lu D
    Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levonorgestrel-releasing intrauterine device use as an alternative to surgical therapy for uterine leiomyoma.
    Senol T; Kahramanoglu I; Dogan Y; Baktiroglu M; Karateke A; Suer N
    Clin Exp Obstet Gynecol; 2015; 42(2):224-7. PubMed ID: 26054124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.
    Pakarinen P; Lähteenmäki P; Rutanen EM
    Acta Obstet Gynecol Scand; 1999 May; 78(5):423-8. PubMed ID: 10326889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy.
    Inki P; Hurskainen R; Palo P; Ekholm E; Grenman S; Kivelä A; Kujansuu E; Teperi J; Yliskoski M; Paavonen J
    Ultrasound Obstet Gynecol; 2002 Oct; 20(4):381-5. PubMed ID: 12383322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the Levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users.
    Gorgen H; Api M; Akça A; Cetin A
    Arch Gynecol Obstet; 2009 Jun; 279(6):835-40. PubMed ID: 19018547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of levonorgestrel - IUD in the treatment of uterine myoma in Thai women.
    Jindabanjerd K; Taneepanichskul S
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S147-51. PubMed ID: 17726816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study.
    Gunes M; Ozdegirmenci O; Kayikcioglu F; Haberal A; Kaplan M
    J Minim Invasive Gynecol; 2008; 15(6):735-8. PubMed ID: 18971138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower abdominal pain and back pain among women treated for menorrhagia: a five-year randomized controlled trial.
    Heliövaara-Peippo S; Halmesmäki K; Hurskainen R; Teperi J; Grenman S; Kivelä A; Kujansuu E; Tuppurainen M; Vuorma S; Yliskoski M; Paavonen J
    Acta Obstet Gynecol Scand; 2009; 88(12):1389-96. PubMed ID: 19878089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women--effects on bleeding patterns, ovarian function and genital shedding of HIV.
    Heikinheimo O; Lehtovirta P; Suni J; Paavonen J
    Hum Reprod; 2006 Nov; 21(11):2857-61. PubMed ID: 16880227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
    Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma.
    Kriplani A; Awasthi D; Kulshrestha V; Agarwal N
    Int J Gynaecol Obstet; 2012 Jan; 116(1):35-8. PubMed ID: 21959070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma.
    Socolov D; Blidaru I; Tamba B; Miron N; Boiculese L; Socolov R
    Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):480-7. PubMed ID: 21942657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
    Cihangir U; Ebru A; Murat E; Levent Y
    Int J Gynaecol Obstet; 2013 Nov; 123(2):146-9. PubMed ID: 24028852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.